Allergy skin testing in predicting adverse reactions to fluorescein: A prospective clinical study

Acta Ophthalmologica

Volumn 89, Issue 5, 2011, Pages 480-483

  Kalogeromitros, Dimitrios C ^a   Makris, Michael P ^a   Aggelides, Xenophon S ^a   Mellios, Anagnostis I ^a   Giannoula, Fani C ^a   Sideri, Kyriaki A ^a   Rouvas, Alexander A ^b   Theodossiadis, Panagiotis G ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

adverse reaction; anaphylactoid; anaphylaxis; fluorescein; hypersensitivity; skin test

Indexed keywords

ADRENALIN; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID DERIVATIVE; FLUORESCEIN SODIUM; LEVOSETIRIZINE; METHYLPREDNISOLONE; RANITIDINE; STEROID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANGINA PECTORIS; ANGIONEUROTIC EDEMA; ARTICLE; ATOPY; BACKACHE; CLINICAL TRIAL; DIAPHORESIS; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DIZZINESS; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; ERYTHEMA; FEMALE; FLUORESCENCE ANGIOGRAPHY; FLUSHING; HEART INFARCTION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NAUSEA AND VOMITING; PREDICTION; PRICK TEST; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SKIN TEST; TACHYCARDIA; URTICARIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; DRUG HYPERSENSITIVITY; FEMALE; FLUORESCEIN; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT DYES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN TESTS; YOUNG ADULT;

EID: 79960431595     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01722.x     Document Type: Article

References (24)

1. Alvis DL, (1985): Twenty-fifth anniversary of fluorescein angiography. Arch Ophthalmol 103: 1269. (Pubitemid 15230605)
2. Brockow K, Romano A, Blanca M, Ring J, Pichler W, &, Demoly P, (2002): General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 57: 45-51. (Pubitemid 34146185)
3. Chazan BI, Balodimos MC, &, Koncz L, (1971): Untoward effects of fluorescein retinal angiopathy in diabetic patients. Ann Ophthalmol 3: 42.
4. Elis PP, Schoenberger M, &, Rendi MA, (1980): Antihistamines as prophylaxis against side reactions to intravenous fluorescein. Trans Am Ophthalmol Soc 78: 190-205. (Pubitemid 11035012)
5. Fineschi V, Monasterolo G, Rosi R, &, Turillazzi E, (1999): Fatal anaphylactic shock during a fluorescein angiography. Forensic Sci Int 100: 137-142. (Pubitemid 29142425)
6. Greene GS, Bell LW, Hitching RA, &, Spaeth GL, (1976): Adverse reaction to intravenous fluorescein: evidence for sex difference. Ann Ophthalmol 8: 533-536.
7. Justise J Jr, Paton D, Beyer CR, &, Seddon GG, (1977): Clinical comparison of 10 percent and 25 percent intravenous sodium fluorescein solutions. Arch Ophthalmol 95: 2015-2016.
8. Kalogeromitros D, Makris M, Rouvas A, Theodossiadis P, Spanoudaki N, &, Papaioannou D, (2007): Skin testing and adverse reactions in fluorescein: a prospective study. Allergy Asthma Proc 28: 472-476.
9. Karhunen U, Raitta C, &, Kala R, (1986): Adverse reactions to fluorescein angiography. Acta Ophthalmol 64: 282-286. (Pubitemid 16068372)
10. Knowles S, Weber E, &, Berbrayer C, (2007): Allergic rection to fluorescein dye: successful one-day desensitization. Can J Ophthalmol 42: 329-330. (Pubitemid 46713698)
11. Kwan A, Barry C, McAllister I, &, Constable I, (2006): Fluorescein angiography and adverse drug reactions revised: the Lions Eye experience. Clin Experiment Ophthalmol 34: 33-38. (Pubitemid 43379368)
12. Kwiterovich KA, Maguire MG, Murphy RP, et al., (1991): Frequency of adverse systemic reactions after fluorescein angiography: results of a prospective study. Ophthalmology 98: 1139-1142.
13. Lieberman P, Kemp SF, Oppenheimer J, et al., (2005): The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115: S483-S523. (Pubitemid 40327251)
14. Lira RP, Oliveira CL, Marques MV, Silva AR, &, Pessoa Cde C, (2007): Adverse reactions of fluorescein angiography: a prospective study. Arq Bras Oftalmol 70: 615-618.
15. McLauchlan R, Waterman H, &, Waterman C, (2001): Ethnic variation in fluorescein angiography induced nausea and vomiting. Eye 15: 159-162. (Pubitemid 32377653)
16. Musa F, Muen WJ, Hancock R, et al., (2006): Adverse effects of fluorescein angiography in hypertensive and elderly patients. Acta Ophthalmol Scand 84: 740-742. (Pubitemid 44688321)
17. Nucera E, Schiavino D, Merendino E, et al., (2003): Succesful fluorescein desensitization. Allergy 58: 458.
18. Patz A, Finkelstein D, Fine SL, &, Murphy RP, (1986): The role of fluorescein angiography in national collaborative studies. Ophthalmology 93: 1466-1470. (Pubitemid 17211869)
19. Singerman LJ, (1986): Fluorescein angiography: practical role in the office management of macular diseases. Ophthalmology 93: 1209-1215. (Pubitemid 17211520)
20. Stein MR, &, Parker CW, (1971): Reactions following intravenous fluorescein. Am J Ophthalmol 72: 861-868.
21. Centers for Medicare and Medicaid Services, USA (2006) Top 200 Level I Current Procedural Terminology Codes (FFA procedure code 92235). Available from:.
22. Trindade-Porto C, Alonso-Llamazares A, Robledo T, et al., (1999): Fluorescein-induced adverse reaction. Allergy 54: 1230.
23. Yannuzzi L, Rohrer K, Tindel L, et al., (1986): Fluorescein angiography complication survey. Ophthalmology 93: 611-617. (Pubitemid 16086713)
24. Zografos L, (1983): International survey on the incidence of severe or fatal complications which may occur during fluorescein angiography. J Fr Ophtalmol 6: 495-506.